RM
At a glance
Registered since
2024
Senate LDA system
Clients
1
last 3 years
Filings
3
11 agencies contacted
Activity
filings by quarter
Works on
Specific issues
DE+I issues including the Equality Act.
Drug Supply Chain Security Act (DSCSA); Education on supply chain issues, raw material shortages, drug shortages, ports and transportation issues, domestic manufacturing, medical device sterilization; Stop Drug Shortages Act; Drug Shortage Prevention and Mitigation Act; Supply chain issues and delays related to US borders and ports; Issues related to the medical supply chain and transportation bottlenecks.
Fast pass for critical cargo (H.R. 6140 Facilitating Access to Swiftly Transport Goods during a Publicly Announced State of Emergency Situation Act); the National Defense Authorization Act (H.R. 8070); provider reimbursement, workforce shortages, pandemic preparedness, and product shortages.
Issues related to drug pricing, pharmacies, provider status, biosimilars, cell and gene therapy, behavioral health; Equitable Community Access to Pharmacist Services Act (H.R. 1770 / S. 2477); VALID Act (H.R. 2369); Issues related to Medicare provider cuts; Hospital Inpatient Services Modernization Act (H.R.8260); Telehealth Modernization Act of 2024 (H.R. 7623); Appropriations report language requests in support of the Food as Medicine initiative and examining drug shortages policies; Cybersecurity in healthcare; Issues related to cybersecurity attacks and the effects on pharmacy.
Issues related to tax reform and 2017 Tax Cuts and Jobs Act.
Issues related to the proposed modifications to the 900MHz ISM Band and Radio Frequency Identification (RFID) technology.